GLO1/Aβ-mediated mitochondrial and synaptic injury in Alzheimer's disease
GLO1/Aβ 介导的阿尔茨海默病线粒体和突触损伤
基本信息
- 批准号:10639086
- 负责人:
- 金额:$ 239.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:Abeta clearanceAccelerationAddressAdvanced Glycosylation End ProductsAffectAgeAlzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAlzheimer&aposs disease therapyAmyloidAmyloid beta-ProteinAmyloidosisAttenuatedBehavioralBrainBrain PathologyCerebrumColorDLG4 geneDepositionDiseaseDisease ProgressionDrug Metabolic DetoxicationEnzymesEquilibriumExcitatory SynapseExhibitsFunctional disorderGenerationsGenetic Predisposition to DiseaseGlucoseHippocampusHumanHyperactivityImpaired cognitionImpairmentIn VitroInflammationInflammation MediatorsInflammatoryInflammatory ResponseInhibitory SynapseInjuryInnate Immune ResponseLactoylglutathione LyaseLate Onset Alzheimer DiseaseLinkMediatingMemoryMemory impairmentMetabolicMitochondriaMusNeuronal PlasticityNeuronsOutcomePathogenicityPathologicPathologyPeptide MetabolismPhagocytosisPilot ProjectsProductionPyruvaldehydeRegulationRisk FactorsRoleSeizuresSenile PlaquesSignal TransductionStressSynapsesSynapsinsSynaptic TransmissionSynaptosomesTestingTherapeuticTherapeutic AgentsVisualVisual CortexVisualizationabeta accumulationage relatedaging brainamyloid pathologyfamilial Alzheimer diseasefollow-upgain of functionglycationimprovedin vivoin vivo two-photon imagingmemory recognitionmitochondrial dysfunctionmouse modelneuroinflammationneuronal excitabilitynovelnovel therapeuticspostsynapticpresynapticpreventsynaptic failuresynaptic functionsynaptic pruningtrafficking
项目摘要
Summary
Mitochondrial dysfunction and synaptic damage are early pathological features of Alzheimer’s disease (AD)-
affected brain1-5 and aging brains. Memory impairment in AD is a manifestation of brain pathologies such as
accumulation of amyloid-β peptide (Aβ) and mitochondrial damage. The underlying pathogenic mechanisms and
effective disease modifying therapies for AD remain elusive. Age is a strong risk factor for the onset and
progression of AD, particularly late-onset AD. Age-related metabolic changes increase generation and deposition
of toxic metabolites such as glucose-derived methylglyoxal (MG) and advanced glycation endproducts (AGEs)
Glyoxalase 1 (GLO1) is a key/initial enzyme responsible for eliminating and
detoxifying MG to prevent the formation of AGEs. So far, little is known about the role of GLO1 on Aβ-induced
mitochondrial and amyloid pathology, neuroinflammation, synaptic and cognitive dysfunction in AD and AD-
linked mouse models
in AD- and Aβ-affected brain.
. It is unclear whether neuronal GLO1 is mechanistic linker between mitochondrial
dysfunction and neuroinflammaton and synaptic injury and if gain of neuronal GLO1 could alleviate amyloid
We hypothesize
that in AD superimposed Aβ, excessive accumulation of MG/AGEs and impaired GLO1 function serve
to accelerate and exaggerate amyloid pathology, leading to mitochondrial
and synaptic stress, thus, clearance of Aβ and AGEs by gain of GLO1 may be of importance in preventing
pathology and synaptic and cognitive dysfunction and slow down disease progression in AD.
as
causative endogenous danger signals
amyloid and mitochondrial pathology. Utilizing novel gain-of-function neuronal GLO1 mice in AD mouse model
and multi-color two-photon in vivo imaging to simultaneously visualize excitatory and inhibitory synapses in the
same neurons, we will explore new mechanism underlying GLO1-dependent Aβ metabolism and mitochondrial
alterations and address whether GLO1 signaling is protective or destructive to neurons in amyloid pathology to
fully establish the benefits/pitfalls of enhancing GLO1 as a therapeutic strategy in AD.
摘要
线粒体功能障碍和突触损伤是阿尔茨海默病(AD)的早期病理特征。
受影响的大脑1-5和老化的大脑。阿尔茨海默病的记忆障碍是大脑病理的一种表现,例如
淀粉样蛋白β多肽(Aβ)蓄积与线粒体损伤。潜在的致病机制和
治疗阿尔茨海默病的有效的疾病修正疗法仍然难以找到。年龄是发病和发病的强烈危险因素
阿尔茨海默病的进展,尤其是晚发性AD。与年龄相关的代谢变化增加生成和沉积
有毒代谢产物,如葡萄糖衍生的甲基乙二醛(MG)和晚期糖基化终末产物(AGEs)
乙二酸酶1(GLO1)是一种关键的/起始酶,负责清除和
解毒MG,防止AGEs的形成。到目前为止,关于Glo1在β诱导的血管紧张素转换酶中的作用还知之甚少
AD和AD患者的线粒体和淀粉样蛋白病理、神经炎症、突触和认知功能障碍
链接的小鼠模型
在AD和β感染的大脑中。
。目前尚不清楚神经元GLO1是否是线粒体之间的机械连接物
功能障碍与神经炎性和突触损伤以及神经元GLO1的获得是否可以减轻淀粉样蛋白
我们假设
AD合并Aβ时,MG/AGEs过度积聚,GLO1功能受损
加速和夸大淀粉样蛋白病理,导致线粒体
因此,通过获得β清除A GLO1和AGEs可能在预防
病理、突触和认知功能障碍,减缓阿尔茨海默病的疾病进展。
AS
致因性内源性危险信号
淀粉样蛋白和线粒体病理学。新型功能获得性神经元GLO1小鼠在AD模型中的应用
和多色双光子体内成像,同时显示兴奋性和抑制性突触
同样的神经元,我们将探索Glo1依赖的Aβ代谢和线粒体的新机制
改变和解决GLO1信号对淀粉样蛋白病理中的神经元是保护还是破坏
充分确立增强GLO1作为AD治疗策略的利弊。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jaichandar Subramanian其他文献
Jaichandar Subramanian的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jaichandar Subramanian', 18)}}的其他基金
Synapse structural dynamics and memory loss in mouse models of Alzheimers disease
阿尔茨海默病小鼠模型中的突触结构动力学和记忆丧失
- 批准号:
10385712 - 财政年份:2019
- 资助金额:
$ 239.75万 - 项目类别:
Synapse structural dynamics and memory loss in mouse models of Alzheimers disease
阿尔茨海默病小鼠模型中的突触结构动力学和记忆丧失
- 批准号:
10599269 - 财政年份:2019
- 资助金额:
$ 239.75万 - 项目类别:
相似海外基金
SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
- 批准号:
2400967 - 财政年份:2024
- 资助金额:
$ 239.75万 - 项目类别:
Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328975 - 财政年份:2024
- 资助金额:
$ 239.75万 - 项目类别:
Continuing Grant
EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
- 批准号:
NE/Y000080/1 - 财政年份:2024
- 资助金额:
$ 239.75万 - 项目类别:
Research Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
- 批准号:
10112700 - 财政年份:2024
- 资助金额:
$ 239.75万 - 项目类别:
Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328973 - 财政年份:2024
- 资助金额:
$ 239.75万 - 项目类别:
Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328972 - 财政年份:2024
- 资助金额:
$ 239.75万 - 项目类别:
Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332916 - 财政年份:2024
- 资助金额:
$ 239.75万 - 项目类别:
Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332917 - 财政年份:2024
- 资助金额:
$ 239.75万 - 项目类别:
Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328974 - 财政年份:2024
- 资助金额:
$ 239.75万 - 项目类别:
Continuing Grant
Radiation GRMHD with Non-Thermal Particle Acceleration: Next-Generation Models of Black Hole Accretion Flows and Jets
具有非热粒子加速的辐射 GRMHD:黑洞吸积流和喷流的下一代模型
- 批准号:
2307983 - 财政年份:2023
- 资助金额:
$ 239.75万 - 项目类别:
Standard Grant